Graig Suvannavejh analyst MIZUHO

Currently out of the existing stock ratings of Graig Suvannavejh, 126 are a BUY (65.63%), 60 are a HOLD (31.25%), 6 are a SELL (3.13%).

Graig Suvannavejh

Work Performance Price Targets & Ratings Chart

Analyst Graig Suvannavejh, currently employed at MIZUHO, carries an average stock price target met ratio of 62.14% that have a potential upside of 35.58% achieved within 128 days.

Graig Suvannavejh’s has documented 394 price targets and ratings displayed on 41 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on BTAI, BioXcel Therapeutics at 11-Sep-2025.

Wall Street Analyst Graig Suvannavejh

Analyst best performing recommendations are on BCYC (BICYCLE THERAPEUTICS LTD).
The best stock recommendation documented was for BCYC (BICYCLE THERAPEUTICS LTD) at 6/17/2019. The price target of $14 was fulfilled within 1 day with a profit of $0.76 (5.74%) receiving and performance score of 57.4.

Average potential price target upside

ALEC Alector ARQT Arcutis Biotherapeutics  BTAI BioXcel Therapeutics CERE Cerevel Therapeutics Holdings CYTK Cytokinetics FLXN Flexion Therapeutics HALO Halozyme Therapeutics HRMY Harmony Biosciences Holdings INSM Insmed ITCI Intracellular Th JAZZ Jazz Pharmaceuticals PLC KOD Kodiak Sciences ORTX Orchard Therapeutics PLC TGTX TG Therapeutics ATHA Athira Pharma  GMTX Gemini Therapeutics MOR MorphoSys AG ADR RYTM Rhythm Pharmaceuticals XEC Cimarex Energy Co AXSM Axsome Therapeutics RAIN Rain Therapeutics ADVM Adverum Biotechnologies AMLX Amylyx Pharmaceuticals HZNP Horizon Pharma PLC IMCR Immunocore Holdings Ltd IMTX Immatics NV MNTA Momenta Pharmaceuticals PTLA Portola Pharmaceuticals TCDA Tricida AUTL Autolus Therapeutics Ltd EYPT Eyepoint Pharmaceuticals KRTX Karuna Therapeutics TERN Terns Pharmaceuticals VIGL Vigil Neuroscience APLS Apellis Pharmaceuticals CRVS Corvus Pharmaceuticals VALN Valneva SE ADR ADAP Adaptimmune Therapeutics Plc BCYC Bicycle Therapeutics Ltd CRBP Corbus Pharmaceuticals IMRX Immuneering Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$5

$1.68 (50.60%)

$5

13 days ago
(25-Sep-2025)

1/4 (25%)

$2.07 (70.65%)

70

Buy

$3.5

$0.18 (5.42%)

$9

2 months 10 days ago
(28-Jul-2025)

1/6 (16.67%)

$1.74 (98.86%)

24

Buy

$7

4 months 29 days ago
(09-May-2025)

0/5 (0%)

$5.34 (321.69%)

Hold

$4

$0.68 (20.48%)

$15

9 months 22 days ago
(16-Dec-2024)

1/4 (25%)

$2.02 (102.02%)

128

Sell

$3

$-0.32 (-9.64%)

$10

10 months 12 days ago
(26-Nov-2024)

2/6 (33.33%)

$0.43 (16.73%)

308

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Graig Suvannavejh is most bullish on?

Potential upside of $20.72 has been obtained for HRMY (HARMONY BIOSCIENCES HOLDINGS)

Which stock is Graig Suvannavejh is most reserved on?

Potential downside of -$47.18 has been obtained for INSM (INSMED)

What Year was the first public recommendation made by Graig Suvannavejh?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?